7.65 (0.47%) Sun Pharmaceutical Industries is going to replace its domestic formulations distributor Aditya Medisales with its own subsidiary in the backdrop of a second whistleblower complaint filed against the company. This change will be made effective by Q1FY20, post receipt of all requisite regulatory approvals.
Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.